Value-Based Care Models Can Help Pharmacies Improve Operations
Drug Topics
JUNE 18, 2024
Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy.
Tue.Jun 18, 2024
201 
Kansas AG accuses Pfizer of misrepresenting COVID vaccine, hiding safety risks in lawsuit
Fierce Pharma
JUNE 18, 2024
Kansas Attorney General is accusing Pfizer of "misrepresenting" its vaccine's safety and efficacy in a 179-page civil suit.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Approves Pneumococcal 21-Valent Conjugate Vaccine Capvaxive
Drug Topics
JUNE 18, 2024
The vaccine covers 8 serotypes not currently covered by any FDA-approved pneumococcal vaccines.
Opinion: Long Covid feels like a gun to my head
STAT
JUNE 18, 2024
I have spent my career studying infectious diseases that fall under the heading of neglected tropical diseases. Now I have a neglected disease — long Covid — an incurable (for now and for me) disease. As a medical anthropologist working in global health, I thought I understood the despair of poor health. I didn’t. I join 7% of the U.S. adult population — or about 18 million Americans — who have experienced long Covid.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Q&A: How Will the FDA Panel's Decision on MDMA Impact the Future of Psychedelic Medicine?
Drug Topics
JUNE 18, 2024
Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses what the future looks like for psychedelic treatments.
Opinion: With the threat of H5N1 bird flu, hospitals must stay prepared
STAT
JUNE 18, 2024
A third case of mammal-to-human transmission of the highly pathogenic H5N1 bird flu virus has been reported in the United States. This latest case, involving a dairy worker in Michigan , raises concerns due to the individual exhibiting respiratory symptoms, highlighting the pandemic potential of this virus. U.S. hospitals need to prepare for the worst and hope for the best.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Another heat wave is hitting the U.S. Here’s what you need to know
STAT
JUNE 18, 2024
Extreme heat is coming this week in many parts of the United States. The Midwest and Northeast in particular will see weather that puts them in the National Weather Service’s highest heat risk category — when lack of cooling or hydration can put almost anyone in harm’s way. It’s a new labeling system for the NWS, which launched the experimental rating at the end of April with the Centers for Disease Control and Prevention in response to the growing danger of extreme h
Ensure Patients Properly Use Topical Antifungal Agents
Pharmacy Times
JUNE 18, 2024
Pharmacists can also counsel on prevention measures and self-management for fungal infections
STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease
STAT
JUNE 18, 2024
A 10-person startup called Marea said Tuesday that it had raised $190 million to help develop a drug to lower a type of cholesterol — what scientists call “remnant cholesterol” — that could represent a new way of attacking cardiovascular disease. The story of that drug, the protein that it targets, and the gene that codes for that protein (both are called ANGPTL4) says a lot about why medicines are so tough to develop and why heart disease remains the bigges
Diabetes and the Skin: Complications and Prevention Tips
Drug Topics
JUNE 18, 2024
Skin complications are common in patients with diabetes, but pharmacists can recommend several easy measures to help.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
To treat obesity in children, task force favors behavioral therapy over drugs like Wegovy
STAT
JUNE 18, 2024
A national advisory organization has come down on the side of behavioral interventions, not obesity medications, to help children 6 and older with high BMI improve their health, wading into the debate over prescribing the blockbusters for kids before their long-term consequences are better understood. On Tuesday, the United States Preventive Services Task Force issued recommendations encouraging clinicians to provide or refer children and adolescents 6 years or older with a high body mass index
Novant Health gives up $320M hospital deal after FTC secures appeals court injunction
Fierce Healthcare
JUNE 18, 2024
Novant Health is throwing in the towel on its $320 million plan to purchase two Community Health Systems hospitals after the Federal Trade Commission (FTC) scored an injunction on the deal from an | "With the FTC’s continued roadblocks we do not see a way to finalize this transaction," a spokesperson for the nonprofit system said Tuesday.
STAT+: To feed an AI that designs new enzymes, Basecamp hunts rare proteins at the world’s end
STAT
JUNE 18, 2024
Not many AI companies have expeditions to the rainforest on the calendar, or need scientists who’ve lived in Antarctica on the payroll. “One of them was the diving instructor for Jason Momoa,” said Philipp Lorenz, chief technology officer at Basecamp Research. “She’s one of our field scientists.” Basecamp, headquartered in London, positions itself as the “bridge between biodiversity and biotech.
AHIP 2024: Not just a buzzword—payers envision AI’s future
Fierce Healthcare
JUNE 18, 2024
You can’t spell AHIP without AI. | Health insurance executives are captivated by artificial intelligences' use cases. Here's where they see advancements on the horizon.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
On the road to eliminate rabies, Gavi announces plan to improve human vaccination
STAT
JUNE 18, 2024
Rabies has been in global health’s crosshairs for years. Around the world, the viral infection kills about 70,000 people a year — and since as early as 2015, groups including Gavi, the Vaccine Alliance, have had plans to shore up vaccine efforts to reduce the number. At one point, Gavi planned to include human rabies vaccines in its 2021 investment strategy — but then the Covid-19 pandemic got in the way.
Meeting Preview: McKesson ideaShare 2024
Drug Topics
JUNE 18, 2024
From the Health Mart Pharmacy of the Year award presentation to general sessions covering pharmacy profitability, community impact, and much more, see what’s to come at this year’s meeting in New Orleans.
AstraZeneca's Truqap misses the mark in late-stage triple-negative breast cancer trial
Fierce Pharma
JUNE 18, 2024
While AstraZeneca’s Truqap bears the distinction of being the first AKT inhibitor to pass muster with the U.S. | In the late-stage CAPItello-290 study, Truqap plus the chemotherapy paclitaxel failed to help extend the lives of patients with locally advanced or metastatic triple-negative breast cancer (TNBC) over paclitaxel and placebo alone, AstraZeneca said Tuesday.
FDA Approves Pembrolizumab With Chemotherapy to Treat Adult Patients With Endometrial Carcinoma
Pharmacy Times
JUNE 18, 2024
The indication is for adult patients with primary advanced or recurrent endometrial carcinoma and is the third indication that pembrolizumab has received for this disease state.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Avoiding the pharma ‘junk pile’ with launch readiness, pipeline rigor and ‘quick kills’
PharmaVoice
JUNE 18, 2024
Drug launches have underperformed expectations at a high rate, and pharmas need to get better at thinning the pipeline to make room for the real wins, says a life sciences consultant.
12 Questions with Caroline Phillips
pharmaphorum
JUNE 18, 2024
Dive into an exclusive Medscape interview with HCP Caroline Phillips as she shares her insights, experiences, and advice. Discover the key takeaways that can benefit your medical practice.
Intra-Cellular's Caplyta scores again in major depressive disorder as blockbuster expansion comes within reach
Fierce Pharma
JUNE 18, 2024
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disord | Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for its third and potentially most lucrative indication—major depressive disorder.
Neuroplastogens: A novel approach to treat neurological diseases
pharmaphorum
JUNE 18, 2024
Learn about the innovative approach of using neuroplastogens, including psychedelics, to treat neurological diseases. Explore the potential benefits and risks of this novel treatment method.
FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia
Pharmacy Times
JUNE 18, 2024
V116 (Capvaxive; Merck) elicited higher immune responses than the comparator for the serotypes that are unique to the vaccine, according to studies submitted to the FDA.
CDC: Uninsured rate fell by 26% between 2019 and 2023
Fierce Healthcare
JUNE 18, 2024
The uninsured rate in the U.S. has declined by 26% over the past several years, according to new data from the Centers for Disease Control and Prevention. | The uninsured rate in the U.S. has declined by 26% over the past several years, according to new data from the Centers for Disease Control and Prevention.
Johnson & Johnson submits BLA to FDA for lung cancer drug
Pharmaceutical Technology
JUNE 18, 2024
Johnson & Johnson has filed a BLA with the US FDA seeking approval for SC amivantamab for the treatment of non-small cell lung cancer.
Slideshow: Exploring Dementia Risk, Hot Flashes, Oral Health in Postmenopausal Women
Drug Topics
JUNE 18, 2024
Four posters presented at ENDO 2024 explored the interplay of hormones and other factors in postmenopausal women.
Novo Nordisk CEO agrees to testify on semaglutide pricing
pharmaphorum
JUNE 18, 2024
Novo Nordisk CEO agrees to appear at a Senate hearing to defend the pricing of Ozempic and Wegovy in the US.
Methadone Dispensing at Discharge Can Help Shorten Hospital Stays for Patients with OUD
Drug Topics
JUNE 18, 2024
A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.
FDA says yes to MSD’s 21-valent adult pneumococcal jab
pharmaphorum
JUNE 18, 2024
The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults.The 21-valent product – formerly known as V116 – covers a wider range of Streptococcus pneumoniae serotypes than any of MSD’s earlier vaccines and eight that are not covered by any other approved pneumococcal vaccine.
Does Weight Loss Improve Cardiovascular Outcomes?
Drug Topics
JUNE 18, 2024
In a session presented at the 2024 Heart in Diabetes Conference, Neha Pagidipati, MD, MPH, discussed weight change and its effects on cardiovascular complications.
KalVista files first oral on-demand HAE drug with FDA
pharmaphorum
JUNE 18, 2024
KalVista files sebetralstat with the FDA, aiming to make it the first oral, on-demand treatment for rare disease hereditary angioedema (HAE)
STAT+: Freespira bets on slow and steady, amid spectacular digital health collapses
STAT
JUNE 18, 2024
Many digital health companies have crashed and burned after promising investors speedy adoption and huge revenues. Freespira, maker of a software- and device-based treatment for panic and post-traumatic stress disorders, has taken a different strategy: Slowly build to profitability a few thousand patients at a time. Freespira CEO Joe Perekupka told STAT the company believes it will break even by the end of 2025 and will become cash flow positive in 2026.
Pharmacy Department-Driven Initiative to Reduce Subcutaneous Daratumumab Observation Time
Pharmacy Times
JUNE 18, 2024
Observation time on subsequent injections of subcutaneous daratumumab may be safely removed from institutional policies to reduce chair time.
Let's personalize your content